We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+0.19%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$212B
AUM Growth
-$6.07B
Cap. Flow
-$9.1B
Cap. Flow %
-4.29%
Top 10 Hldgs %
20.34%
Holding
10,267
New
1,181
Increased
4,000
Reduced
3,668
Closed
1,180

Top Sells

Rank Stock Value
1
RHT
Red Hat Inc
RHT
+$541M
2
ADBE icon
Adobe
ADBE
+$381M
3
APC
Anadarko Petroleum
APC
+$355M
4
PM icon
Philip Morris
PM
+$339M
5
WP
Worldpay, Inc.
WP
+$317M

Sector Composition

Rank Sector Weight
1 Technology 5.29%
2 Financials 4.31%
3 Industrials 4.01%
4 Healthcare 3.77%
5 Consumer Discretionary 3.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LUMO
8501
PUT
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$52K ﹤0.01%
+3,600
New +$52.8K
MRNS
8502
PUT
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$52K ﹤0.01%
8,450
-4,600
-35% -$37.2K
IMBI
8503
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$52K ﹤0.01%
+9,256
New +$44K
DTEA
8504
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
$52K ﹤0.01%
25,015
-6,351
-20% -$9.85K
EVK
8505
DELISTED
Ever-Glory International Group, Inc.
EVK
$52K ﹤0.01%
15,744
+1,850
+13% +$5.79K
FBRX icon
8506
Forte Biosciences
FBRX
$1.57B
$51K ﹤0.01%
206
-73
-26% -$111K
KODK icon
8507
CALL
Kodak
KODK
$983M
$51K ﹤0.01%
19,300
+8,300
+75% +$20.5K
ONIT
8508
CALL
Onity Group
ONIT
$332M
$51K ﹤0.01%
1,813
+426
+31% +$11.9K
ADMA icon
8509
CALL
ADMA Biologics
ADMA
$2.22B
$50K ﹤0.01%
+11,300
New +$47.2K
AVDL
8510
CALL
DELISTED
Avadel Pharmaceuticals
AVDL
$50K ﹤0.01%
+12,000
New +$30K
GGB icon
8511
CALL
Gerdau
GGB
$9.7B
$50K ﹤0.01%
20,160
-14,994
-43% -$40K
IMNN icon
8512
Imunon
IMNN
$6.77M
$50K ﹤0.01%
167
-26
-13% -$8.9K
MARA icon
8513
Marathon Digital Holdings
MARA
$3.9B
$50K ﹤0.01%
+28,826
New +$58.3K
XIN
8514
DELISTED
Xinyuan Real Estate
XIN
$50K ﹤0.01%
1,222
-465
-28% -$19.4K
LUMO
8515
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$50K ﹤0.01%
3,506
-1,630
-32% -$23.9K
AGTC
8516
CALL
DELISTED
Applied Genetic Technologies Corporation
AGTC
$50K ﹤0.01%
12,000
-2,300
-16% -$8.3K
UNT
8517
PUT
DELISTED
UNIT Corporation
UNT
$50K ﹤0.01%
14,800
-4,900
-25% -$24.1K
MEET
8518
PUT
DELISTED
The Meet Group, Inc. Common Stock
MEET
$50K ﹤0.01%
+15,400
New +$53.5K
VVUS
8519
CALL
DELISTED
Vivus Inc
VVUS
$50K ﹤0.01%
13,100
+2,600
+25% +$9.73K
NES
8520
DELISTED
Nuverra Environmental Solutions, Inc. Common Stock
NES
$50K ﹤0.01%
+11,881
New +$52K
KZIA
8521
Kazia Therapeutics
KZIA
$159M
$49K ﹤0.01%
256
-153
-37% -$20.9K
QUIK icon
8522
QuickLogic
QUIK
$257M
$49K ﹤0.01%
10,012
+1,702
+20% +$10.5K
GRCE
8523
Grace Therapeutics
GRCE
$34.7M
$49K ﹤0.01%
+536
New +$49.6K
ALIM
8524
DELISTED
Alimera Sciences
ALIM
$49K ﹤0.01%
+5,742
New +$52.2K
NBRV
8525
CALL
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$49K ﹤0.01%
99
-23
-19% -$13K

Similar funds

Citadel Advisors's Q3 2019 Portfolio in Review

As of Q3 2019, Citadel Advisors held 10,267 positions worth $212B, down 2.8% from $218B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Citadel Advisors withdrew a net $9.1B in Q3 2019, closing 1,180 positions and reducing 3,668 holdings. Its most notable exit was Red Hat Inc, an estimated $541M position sold in full.

By sector, the portfolio is most concentrated in Technology at 5.3% of assets, down from 5.4% a quarter earlier, followed by Financials and Industrials.

Against the trend, Citadel Advisors opened a new position in KKR & Co worth $200M.

  • Citadel Advisors's largest Q3 2019 buy was KKR & Co: 7,452,706 shares worth $200M.
  • Citadel Advisors added most to Verizon in Q3 2019, an estimated $531M increase.
  • Citadel Advisors's biggest Q3 2019 reduction was Adobe, cutting an estimated $381M.
  • Citadel Advisors fully exited Red Hat Inc in Q3 2019, selling an estimated $541M.
  • Citadel Advisors's ten largest holdings make up 20% of its $212B portfolio in Q3 2019.
  • Citadel Advisors opened 1,181 new positions and closed 1,180 in Q3 2019.
  • Citadel Advisors's portfolio value fell 2.8% quarter-over-quarter to $212B.

Based on Citadel Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.